Quantcast

Latest JC virus Stories

2006-03-08 10:50:18

GAITHERSBURG, Maryland (Reuters) - Biogen Idec and Elan's multiple sclerosis drug Tysabri could be used as a first-choice treatment for some patients if it returns to the market, a U.S. advisory panel said on Wednesday. The committee voted 7-5 in favor of Tysabri as an initial treatment for some patients. The panel was due to vote later Wednesday on whether to recommend resumed sales for the drug, which was pulled from the market in February 2005 after three patients developed a...

2006-03-08 10:49:50

GAITHERSBURG, Maryland (Reuters) - Biogen Idec and Elan's multiple sclerosis drug Tysabri could be used as a first-choice treatment for some patients if it returns to the market, a U.S. advisory panel said on Wednesday. The committee voted 7-5 in favor of Tysabri as an initial treatment for some patients. The panel was due to vote later Wednesday on whether to recommend resumed sales for the drug, which was pulled from the market in February 2005 after three patients developed a...

2006-03-08 01:23:31

By Lisa Richwine GAITHERSBURG, Maryland (Reuters) - A U.S. advisory panel is set to decide on Wednesday whether to urge the return of a Biogen Idec multiple sclerosis drug that was pulled from the market last year when it was linked to a rare, life-threatening infection. The drug, Tysabri, is key for Biogen and marketing partner Elan Corp. It had been dubbed a billion-dollar-a-year seller before the safety concern arose. The companies voluntarily suspended sales in February 2005...


Word of the Day
blee
  • Color; hue; complexion.
This word is Middle English in origin.
Related